Qiagen (QGEN) Free Cash Flow (2008 - 2025)
Qiagen (QGEN) free cash flow from Dec 31, 2008 to Dec 31, 2025. The TTM Qiagen (QGEN) free cash flow is $453M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Qiagen (QGEN) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -10.49% |
| 3 Years | -8.21% |
| 5 Years | +6.88% |
| 10 Years | +7.51% |
| All Time | +7.45% |
Annual Free Cash Flow change of Qiagen (QGEN)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | $453M | -10.49% |
| 2024 | $506M | +63.48% |
| 2023 | $310M | -47.15% |
| 2022 | $586M | +30.49% |
| 2021 | $449M | +38.18% |
| 2020 | $325M | +52.67% |
| 2019 | $213M | -14.75% |
| 2018 | $250M | +26.96% |
| 2017 | $197M | -26.35% |
| 2016 | $267M | +21.55% |
| 2015 | $220M | +9.11% |
| 2014 | $201M | +15.40% |
| 2013 | $174M | +22.12% |
| 2012 | $143M | -9.55% |
| 2011 | $158M | -7.66% |
| 2010 | $171M | +3.80% |
| 2009 | $165M | +23.41% |
| 2008 | $134M | N/A |
Comparison Qiagen (QGEN) five years free cash flow CAGR with competitors
Qiagen (QGEN) five years free cash flow CAGR is 6.88%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| CDNA | Caredx Inc | 83.64% | +1115.94% |
| CRL | Charles River Laboratories International Inc | 42.96% | +524.61% |
| EXAS | Exact Sciences Corp | 37.68% | +447.72% |
| CSTL | Castle Biosciences Inc | 24.94% | +262.57% |
| MEDP | Medpace Holdings Inc | 24.83% | +260.99% |
| PSNL | Personalis Inc | 11.39% | +65.58% |
| ICLR | Icon Plc | 10.77% | +56.51% |
| GH | Guardant Health Inc | 10.63% | +54.52% |
| IDXX | Idexx Laboratories Inc | 10.21% | +48.36% |
| RDNT | Radnet Inc | 8.77% | +27.45% |
| MTD | Mettler-Toledo International Inc | 1.98% | -71.25% |
| ILMN | Illumina Inc | 1.82% | -73.54% |
| IQV | IQVIA Holdings Inc | 0.31% | -95.55% |